Compare DCM Shriram Fine with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- The company has reported losses. Due to this company has reported negative ROE
- PAT(Q) At Rs -4.08 cr has Fallen at -866.2% (vs previous 4Q average)
- NET SALES(Q) Lowest at Rs 93.08 cr
- PBDIT(Q) Lowest at Rs -2.50 cr.
Risky - Negative Operating Profits
Falling Participation by Institutional Investors
Stock DNA
Commodity Chemicals
INR 221 Cr (Micro Cap)
NA (Loss Making)
44
1.57%
-0.21
-2.14%
1.11
Total Returns (Price + Dividend) 
Latest dividend: 0.4 per share ex-dividend date: Jul-01-2026
Risk Adjusted Returns v/s 
Returns Beta
News

DCM Shriram Fine Chemicals Ltd is Rated Strong Sell
DCM Shriram Fine Chemicals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 20 May 2026, reflecting a comprehensive assessment of the company’s current standing. However, all fundamentals, returns, and financial metrics discussed here are based on the latest data as of 08 August 2026, providing investors with an up-to-date view of the stock’s performance and outlook.
Read full news article
DCM Shriram Fine Chemicals Ltd is Rated Strong Sell
DCM Shriram Fine Chemicals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 July 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.
Read full news article
DCM Shriram Fine Chemicals Ltd Locks at Upper Circuit With 4.97% Gain — Buyers Queue, Sellers Absent
At Rs 28.11, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. DCM Shriram Fine Chemicals Ltd locked at its upper circuit of 4.97% on 21 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article Announcements 
Update In CIN
07-Aug-2026 | Source : BSEUpdate in Corporate Identification Number : L24296DL2021PLC387429
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011
06-Aug-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Urvashi Tilakdhar
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011
06-Aug-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suman Bansi Dhar
Corporate Actions 
No Upcoming Board Meetings
DCM Shriram Fine Chemicals Ltd has declared 20% dividend, ex-date: 01 Jul 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.0%)
Held by 13 FIIs (1.03%)
Lala Bansi Dhar & Sons (13.83%)
Life Insurance Corporation Of India (4.64%)
26.62%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -3.68% vs -0.22% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -151.85% vs 40.44% in Dec 2025
Annual Results Snapshot (Standalone) - Mar'26
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period






